Qualitative detection of the Marburg I alloenzyme of factor VII-activating protease by an immunoassay and its comparison to PCR testing.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 20828365)

Published in Clin Chem Lab Med on September 10, 2010

Authors

Herbert Schwarz1, Sina Stephan, Johannes J Sidelmann, Bodo Fischer, Harald Althaus, Martin Hahn, Andreas Kappel, Matthias Ehm, Frank Vitzthum

Author Affiliations

1: Siemens Healthcare Diagnostics Products GmbH, Marburg, Germany.

Articles by these authors

Investigations on DNA intercalation and surface binding by SYBR Green I, its structure determination and methodological implications. Nucleic Acids Res (2004) 3.45

Constitutive activation of the Ras-Raf signaling pathway in metastatic melanoma is associated with poor prognosis. J Carcinog (2004) 3.02

First certified reference material for cystatin C in human serum ERM-DA471/IFCC. Clin Chem Lab Med (2010) 2.95

HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples. Proteomics (2005) 2.71

Hypoxia-inducible factor-1alpha mRNA contains an internal ribosome entry site that allows efficient translation during normoxia and hypoxia. Mol Biol Cell (2002) 2.61

Beta-trace protein, cystatin C, beta(2)-microglobulin, and creatinine compared for detecting impaired glomerular filtration rates in children. Clin Chem (2002) 2.17

Cooperative interaction of hypoxia-inducible factor-2alpha (HIF-2alpha ) and Ets-1 in the transcriptional activation of vascular endothelial growth factor receptor-2 (Flk-1). J Biol Chem (2002) 2.15

Quantification of coagulation factor XIII activity by a thio-NADH based assay using factor XIII immuno-depleted plasma as a diluent for calibration. Clin Chem Lab Med (2010) 1.39

MicroRNA in vitro diagnostics using immunoassay analyzers. Clin Chem (2015) 1.39

Immunoassay and antibody microarray analysis of the HUPO Plasma Proteome Project reference specimens: systematic variation between sample types and calibration of mass spectrometry data. Proteomics (2005) 1.38

Automated model-based vertebra detection, identification, and segmentation in CT images. Med Image Anal (2009) 1.36

Comprehensive analysis of microRNA profiles in multiple sclerosis including next-generation sequencing. Mult Scler (2013) 1.16

Randomized controlled trial of cholecalciferol supplementation in chronic kidney disease patients with hypovitaminosis D. Nephrol Dial Transplant (2012) 1.13

Mechanisms underlying the impact of humic acids on DNA quantification by SYBR Green I and consequences for the analysis of soils and aquatic sediments. Nucleic Acids Res (2003) 1.07

A proteomic study of the HUPO Plasma Proteome Project's pilot samples using an accurate mass and time tag strategy. Proteomics (2005) 1.02

Effects of preanalytical variables on peptide and protein measurements in human serum and plasma: implications for clinical proteomics. Expert Rev Proteomics (2006) 1.01

Factor VII-activating protease in patients with acute deep venous thrombosis. Thromb Res (2008) 0.97

Fibrin clot structure in patients with end-stage renal disease. Thromb Haemost (2007) 0.95

N Latex FLC - new monoclonal high-performance assays for the determination of free light chain kappa and lambda. Clin Chem Lab Med (2011) 0.92

Faster recovery without the use of a tourniquet in total knee arthroplasty. Acta Orthop (2014) 0.92

Plasma concentrations of extracellular matrix protein fibulin-1 are related to cardiovascular risk markers in chronic kidney disease and diabetes. Cardiovasc Diabetol (2013) 0.89

Development and multicenter evaluation of the N latex CDT direct immunonephelometric assay for serum carbohydrate-deficient transferrin. Clin Chem (2007) 0.88

Multivariate analysis of the relation between diet and warfarin dose. Eur J Clin Pharmacol (2011) 0.87

Impact of epimerization domains on the intermodular transfer of enzyme-bound intermediates in nonribosomal peptide synthesis. Chembiochem (2006) 0.85

Rapid parallel mutation scanning of gene fragments using a microelectronic protein-DNA chip format. Nucleic Acids Res (2002) 0.81

Intraoperative blood loss during orthognathic surgery is predicted by thromboelastography. J Oral Maxillofac Surg (2012) 0.80

Development of high-throughput chemical extraction techniques and quantitative HPLC-MS/MS (SRM) assays for clinically relevant plasma proteins. J Proteome Res (2010) 0.79

Non-invasive assessments reveal that more than half of randomly selected middle-aged individuals have evidence of subclinical atherosclerosis: a DanRisk substudy. Int J Cardiovasc Imaging (2012) 0.79

Biomarkers of coagulation, fibrinolysis, endothelial function, and inflammation in arterialized venous blood. Blood Coagul Fibrinolysis (2014) 0.79

Tests for the measurement of factor VII-activating protease (FSAP) activity and antigen levels in citrated plasma, their correlation to PCR testing, and utility for the detection of the Marburg I-polymorphism of FSAP. Clin Chem Lab Med (2008) 0.78

A comparative study of the effect of continuous combined conjugated equine estrogen plus medroxyprogesterone acetate and tibolone on blood coagulability. Hum Reprod (2007) 0.78

Similar cardiovascular risk factor profile in screen-detected and known type 2 diabetic subjects. Scand J Prim Health Care (2011) 0.78

Dusart Syndrome in a Scandinavian family characterized by arterial and venous thrombosis at young age. Scand J Clin Lab Invest (2013) 0.76

A second combinatorial immune receptor in monocytes/macrophages is based on the TCRγδ. Immunobiology (2012) 0.76

A 1-year study to compare the hemostatic effects of oral contraceptive containing 20 microg of ethinylestradiol and 100 microg of levonorgestrel with 30 microg of ethinylestradiol and 100 microg of levonorgestrel. Contraception (2005) 0.75

Genetic, clinical and behavioural determinants of vitamin K-antagonist dose--explored through multivariable modelling and visualization. Basic Clin Pharmacol Toxicol (2011) 0.75

Direct chromogenic substrate immuno-capture activity assay for testing of factor VII-activating protease. Clin Chem Lab Med (2011) 0.75

Factor VII-activating protease: sex-related association with coronary artery calcification. Blood Coagul Fibrinolysis (2017) 0.75

Pharmacist-developed sedation protocol and impact on ventilator days. J Pharm Pract (2012) 0.75

Coagulation assays based on the Luminescent Oxygen Channeling Immunoassay technology 1). Clin Chem Lab Med (2011) 0.75

Perceived stress predicts the stability of vitamin K-antagonist treatment of anticoagulant clinic patients. Thromb Haemost (2012) 0.75

Plasma factor VII-activating protease is increased by oral contraceptives and induces factor VII activation in-vivo. Thromb Res (2011) 0.75

Microwave-assisted partial hydrogenation of citral by using ionic liquid-coated porous glass catalysts. ChemSusChem (2011) 0.75

Difference in fibrinolytic capacity in young patients with venous thrombosis or ischaemic stroke. Blood Coagul Fibrinolysis (2014) 0.75